regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. regenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. 

Profile Description

regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

Advancements in medical Science, biology, cell-based therapies, as well as the ever increasing market entry barriers induced by biomedical product regulations and legislations, ask for innovative solutions to create biogical relevant tissue models. It is well known nowadays that these requirements can only be fulfilled if science is able to mimic natural morphologic environments of the third dimension.

At regenHU our ambition is to engineer cutting-edge bioprinting solutions to enable scientific and clinical advancements. Our bioprinters 3DDiscovery™ and BioFactory™ offer a wide selection of high-end professional bioprinting instruments for the driving force of scientific advancements in Tissue Engineering, Regenerative Medicine and Drug Discovery. The 3 outstanding abilities: Modularity, Flexibility and Technical Customization make the 3DDiscovery™ and BioFactory™ bioprinters unique in their field.


We provide a large diversity of printhead technologies to process an extensive biomaterial portfolio, multiple polymerization methods and technical accessories allowing us to adapt and optimize your instrument to your application needs.


The configuration of your instrument can be modified to your needs at any time, allowing your bioprinting hardware to evolve with your specific scientific requirements.


Your application requires precise solutions and with our engineering expertise we are able to extend the hardware capacity of our products to respond to your ever evolving specifications (software, labware or hardware tools).

Our instruments are manufactured according to the highest industrial standards; we aim to exploit the latest technological advancements in order to offer high performance equipment facilitating the transition from R&D to GMP manufacturing.
We have carefully followed the evolution of Tissue Engineering and Regenerative Medicine sciences for over a decade. Our knowledge and experience have convinced us that future breakthroughs in the field will be the result of converging technologies; therefore we have devoted all our efforts to combine these technologies to offer unique solutions connecting bioprinting with Electrospinning and Microfluidics.

Range of Services

  • Switzerland
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services